Notice of Concern (NOC) Accutest Research Laboratories (I) Pvt Ltd, Navi Mumbai, India Published
IS
First human insulins prequalified
M
The first human insulins have been prequalified by WHO: fast-acting human insulin 100 IU/ml and intermediate-acting human insulin 100 IU/ml from Novo Nordisk A/S.
1st Invitation to manufacturers of IVDs medical devices used for the qualitative detection of Mycobacterium tuberculosis complex DNA and mutations associated with drug-resistant tuberculosis to apply for WHO prequalification assessment as of 22 September
IVD
To support the global effort to end the TB epidemic, through the provision of guidance to interested United Nations (UN) and other agencies and WHO Member States in their procurement decisions,
WHO issues its first emergency use listing for a SARS-CoV-2 self-test
IVD
Today, WHO listed the first quality-assured SARS-CoV-2 self-test for emergency use.
Nitrosamine concerns in rifapentine products - Update
M
As previously announced, the nitrosamine impurity, 1-cyclopentyl-4-nitrosopiperazine (CPNP), has been identified in rifapentine products.
The EOI for human insulin now revised to include long-acting insulin analogues
M
The changes to the EOI for human insulin shown below in bold and italic
Suspension of supply of COVID-19 vaccine (COVAXIN®)
V
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
First entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First tocilizumab products for Covid-19 prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: